Hehr, Thomas <br/><br/>
Selective lymph node dissection following hyperfractionated accelerated radio-(chemo-)therapy for advanced head and neck cancer.  [electronic resource] 

 -  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]  Jul 2002 
 - 363-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0179-7158 
<br/><br/><label>Standard No.: </label>10.1007/s00066-002-0965-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Squamous Cell--drug therapy<br/>Combined Modality Therapy<br/>Dose Fractionation, Radiation<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Lymph Node Excision<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Mitomycin--administration & dosage<br/>Neoadjuvant Therapy<br/>Otorhinolaryngologic Neoplasms--drug therapy<br/>Radiation Dosage<br/>Survival Rate